Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - soluzione iniettabile piene pen (sureclick) - darbepoetinum alfa 100 µg, natrii fosfati o, natrii chloridum, polysorbatum 80, acqua per iniectabilia q.s. per una soluzione invece di 0,5 ml corresp., darbepoetinum alfa 200 µg/ml. - stimolazione dell'eritropoiesi - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - soluzione iniettabile piene pen (sureclick) - darbepoetinum alfa 150 µg, natrii fosfati o, natrii chloridum, polysorbatum 80, acqua per iniectabilia q.s. la soluzione per 0,3 ml corresp., darbepoetinum alfa 500 µg/ml. - stimolazione dell'eritropoiesi - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - soluzione iniettabile piene pen (sureclick) - darbepoetinum alfa 300 µg, natrii fosfati o, natrii chloridum, polysorbatum 80, acqua per iniectabilia q.s. la soluzione per 0,6 ml corresp., darbepoetinum alfa 500 µg/ml. - stimolazione dell'eritropoiesi - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - soluzione iniettabile piene pen (sureclick) - darbepoetinum alfa 500 µg, natrii fosfati o, natrii chloridum, polysorbatum 80, acqua per iniectabilia q.s. per la soluzione di pro 1 ml corresp., darbepoetinum alfa 500 µg/ml. - stimolazione dell'eritropoiesi - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - soluzione iniettabile piene pen (sureclick) - darbepoetinum alfa 130 µg, natrii fosfati o, natrii chloridum, polysorbatum 80, acqua per iniectabilia q.s. la soluzione per 0,65 ml corresp., darbepoetinum alfa 200 µg/ml. - stimolazione dell'eritropoiesi - biotechnologika

European Union - Italian - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - altre antianemico preparazioni - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.

European Union - Italian - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - preparazioni antianemiche - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

voisin consulting ch sàrl - vadadustatum - compresse rivestite con film - vadadustatum 150 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 0.38 - 0.58 mg. - anémie associée à l’insuffisance rénale chronique - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

voisin consulting ch sàrl - vadadustatum - compresse rivestite con film - vadadustatum 300 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 0.77 - 1.15 mg. - anémie associée à l’insuffisance rénale chronique - synthetika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

voisin consulting ch sàrl - vadadustatum - compresse rivestite con film - vadadustatum 450 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hypromellosum, silica colloidalis anhydrica, magnesii stearas, pellicule: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.16 - 1.74 mg. - anémie associée à l’insuffisance rénale chronique - synthetika